BVd
BLENREP with bortezomib and dexamethasone
Getting started with BLENREP
What is BLENREP?
BLENREP contains the active substance, belantamab mafodotin, which is made up of two types of medicines that are attached to each other:
- Part 1: a monoclonal antibody
- Part 2: an anticancer medication
In BLENREP, the monoclonal antibody is a protein designed to find the multiple myeloma cells in your body and bind to them. Once attached to the cancer cell, the anticancer medication is released to kill the cancer cells.
Treatment combinations
BLENREP will be given together with other anticancer medicines used to treat multiple myeloma. There are two combinations available. Your doctor will decide which one is right for you.
BPd
BLENREP with pomalidomide and dexamethasone